Avid Bioservices Inc (CDMO)

[bimerkjaere]

Good pt jakedogman1, I don't think any potential partner wants to share development responsibilities with pphm. A buyout, despite the great potential in bavi, is too risky for any big pharma to make. They would have to give at least a 70-80% premium, so you would be looking at up to $500M if an offer was given today.

Of course, just because the companies could be sharing development costs, the major pharma would be driving all decision-making and conducting the trials. I would anticipate a smaller upfront payment and a generous profit sharing for pphm. If bavi would to be a success in Ph III, then the major pharma would make the buyout offer (even though it would be likely in the billions).

IMO